Logo Prima Biomed

Welcome to the Newsroom

05 September 2017

Prima Secures Japanese Patent Grant for Lead Product IMP321 in Infectious Disease



SYDNEY, AUSTRALIA - Prima BioMed Ltd (ASX: PRR; NASDAQ: PBMD) (“Prima”, the “Company”)
announces the grant of patent number 6169734 entitled “Use of Recombinant LAG-3 or the
Derivatives thereof for Eliciting Monocyte Immune Response” by the Japanese Patent Office.